I-type lectins (siglecs) - sequence alignments- CD33-related siglecs - Siglecs 1, 2 and 4 |
|
Sequence alignment of human and mouse CD33-related siglecs
The proteins in this subgroup of siglecs exhibit a high level of similarity to human CD33 (siglec 3). The subgroup has undergone differential expansion in mouse and human. The mouse proteins are termed siglecs E, F, G and H, while the human proteins, in addition to CD33/siglec 3, are designated siglecs 5-12. Indicated above the alignment are structural domains, sequence motifs, intron/exon boundaries deduced from the siglec-10 gene (|), and potential N-linked glycosylation sites (+). Residues that are identical in more than 70% of the aligned sequences are highlighted in green, and residues that are similar in more than 70% of the sequences are highlighted in cyan. Divergent regions are highlighted in grey. Cysteine residues are highlighted in yellow. Three residues involved in sialic acid binding are highlighted in magenta and are shown in the structure of siglec-7: the conserved arginine which makes an electrostatic interaction with sialic acid that is essential for high-affinity binding, plus two hydrophobic aromatic residues. Note that the essential arginine is missing in siglec 12, as it is in certain other primate siglecs and rat siglec H. Cytoplasmic tyrosine-based signaling motifs are highlighted in orange.
NB: Siglec-12 is produced with two alternative N-terminal regions. The longer form, here called siglec-12a, has two V-type immunoglobulin domains whereas the short form, siglec-12b, has the usual single V-type domain. Residue numbers refer to siglec-12a. A number of other siglecs are also subject to alternative splicing. In each case, all the potential domain elements are included in the alignment, but not all are necessarily found within a single siglec isoform.
If alignments appear scrambled please maximize the width of your browser window. |
|
![]() Structure of Siglec-7 CRD Structure adapted from Alphey et al, J Biol Chem 278, 3372 |
|
___________________________________________________________________________________________________________________
|
|
|
| Contact information: | This site is supported by: | |
|
|
|
![]() |
||